D. van der Heijde

发表

Development of a disease activity score based on judgment in clinical practice by rheumatologists.

M. A. van 't Hof, L. V. D. van de Putte, P. van Riel, 1993, The Journal of rheumatology.

Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.

L. V. D. van de Putte, P. van Riel, M. V. van Rijswijk, 1988, Seminars in arthritis and rheumatism.

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients.

M. A. van 't Hof, M. V. van Leeuwen, L. V. D. van de Putte, 1992, British journal of rheumatology.

Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).

M. V. van Leeuwen, L. V. D. van de Putte, P. van Riel, 1995, The Journal of rheumatology.

Can we predict aggressive disease?

A. Young, D. van der Heijde, 1997, Bailliere's clinical rheumatology.

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis

S. van der Linden, P. Geusens, M. Boers, 2005, Annals of the rheumatic diseases.

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

M. V. van Leeuwen, L. V. D. van de Putte, P. van Riel, 1992, Annals of the rheumatic diseases.

Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine.

L. V. D. van de Putte, P. van Riel, D. van der Heijde, 1990, Scandinavian journal of rheumatology.

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis

R. Landewé, D. Heijde, P. Mowinckel, 2008, Annals of the rheumatic diseases.

Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents

A. Boonen, D. Heijde, Ø. Molberg, 2008, Annals of the rheumatic diseases.

Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity

R. Landewé, D. Heijde, Ø. Molberg, 2007, Annals of the rheumatic diseases.

Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis.

M. A. van 't Hof, M. V. van Leeuwen, L. V. D. van de Putte, 1991, The Journal of rheumatology.

A practical exercise in reading RA radiographs by the larsen and sharp methods.

M. Boers, J. Edmonds, M. Lassere, 1999, Journal of Rheumatology.

Modified sharp method: factors influencing reproducibility and variability.

M. A. van 't Hof, P. van Riel, N. de Vries, 2001, Seminars in arthritis and rheumatism.

Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.

M. Boers, J. Edmonds, D. Heijde, 2001, The Journal of rheumatology.

Joint erosions and patients with early rheumatoid arthritis.

D. van der Heijde, D. van der Heijde, 1995, British journal of rheumatology.

Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis.

M. A. van 't Hof, M. V. van Leeuwen, L. V. D. van de Putte, 1992, Arthritis and rheumatism.

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

M. A. van 't Hof, M. V. van Leeuwen, L. V. D. van de Putte, 1990, Annals of the rheumatic diseases.

Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change

S. van der Linden, K. Bruynesteyn, M. Boers, 2004, Annals of the rheumatic diseases.

Smallest detectable difference in radiological progression.

M. Boers, A. Saudan, J. Edmonds, 1999, The Journal of rheumatology.

Foundations of the minimal clinically important difference for imaging.

M. Lassere, D. van der Heijde, K. Johnson, 2001, The Journal of rheumatology.

Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.

M. V. van Leeuwen, L. V. D. van de Putte, P. van Riel, 1994, The Journal of rheumatology.

Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis

R. Tsonaka, S. Cessie, S. le Cessie, 2013, Scandinavian journal of rheumatology.

How to interpret radiological progression in randomized clinical trials?

M. Boers, D. van der Heijde, R. Landewé, 2003, Rheumatology.

Robustness and generalizability of smallest detectable difference in radiological progression.

K. Bruynesteyn, M. Boers, A. Boonen, 2001, The Journal of rheumatology.

Monitoring anti-TNFα treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage

A. Boonen, M. Østergaard, T. Kvien, 2008, Annals of the rheumatic diseases.

Imaging in rheumatoid arthritis: results of group discussions.

D. Felson, M. Boers, H. Paulus, 1999, The Journal of rheumatology.

Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis

G. Alarcón, A. Westfall, L. Hughes, 2008, Annals of the rheumatic diseases.

Reliability, sensitivity to change and feasibility of three radiographic scoring methods for hand osteoarthritis

F. Rosendaal, F. Berenbaum, I. Haugen, 2011, Annals of the rheumatic diseases.

Disease assessment in rheumatoid arthritis.

L. V. D. van de Putte, P. van Riel, D. van der Heijde, 1989, Annals of the rheumatic diseases.

Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.

M. Boers, V. Strand, D. Heijde, 2001, The Journal of rheumatology.

Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.

A. Silman, D. Symmons, M. Suarez‐Almazor, 1999, The Journal of rheumatology.

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

M. V. van Leeuwen, P. van Riel, G. T. te Meerman, 1993, British journal of rheumatology.

Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.

S. van der Linden, K. Bruynesteyn, M. Boers, 2001, The Journal of rheumatology.

Simplified versions of the original disease activity score: validation in the BeSt trial

T. Huizinga, C. Allaart, D. van der Heijde, 2011, Annals of the rheumatic diseases.

Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment?

D. Heijde, D. van der Heijde, D. van der Heijde, 2001, Annals of the rheumatic diseases.

Validity of single variables and indices to measure disease activity in rheumatoid arthritis.

M. A. van 't Hof, P. van Riel, D. van der Heijde, 1993, The Journal of rheumatology.

Response criteria for slow acting antirheumatic drugs.

M. A. van 't Hof, P. van Riel, D. van der Heijde, 1990, Annals of the rheumatic diseases.

Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis

D. Heijde, D. van der Heijde, D. van der Heijde, 2000 .

Optimisation of rheumatic disease assessments in clinical trials, clinical care, and long-term databases.

R. Landewé, D. van der Heijde, 2014, Clinical and experimental rheumatology.